Mycobacterium kansasii: Its presentation, treatment and outcome in HIV infected patients

Journal of Clinical Pathology

Volumn 49, Issue 10, 1996, Pages 821-823

  Rooney, G ^a   Nelson, M R ^a   Gazzard, B ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

HIV infection; Mycobacterium kansasii

Indexed keywords

CLARITHROMYCIN; CLOFAZIMINE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN;

ARTICLE; CLINICAL ARTICLE; DRUG SENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LUNG DISEASE; MYCOBACTERIUM KANSASII; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0029794078     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.10.821     Document Type: Article

References (19)

1. Schraufnagel DE, Leech JA, Pollak B. Mycobacterium kansasii: colonisation and disease. Br J Dis Chest 1986; 80:131-7.
2. Engstrom PF, Dewey GC, Barrett O. Disseminated Mycobacterium kansasii infection. Successful treatment of a patient with pancytopenia. Am J Med 1972;52:533-7.
3. Ahn CH, McLarty JW, Ahn SS, Ahn SI, Hurst GA. Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am Rev Respir Dis 1982;125:388-91
4. Wolinsky E. When is an infection disease? Rev Infect Dis 1981;3:1025-7.
5. Bamberger DM, Driks MR, Gupta MR, O'Connor MC, Jost PM, Neihart RE, et al. Mycobacterium kansasii among patients infected with the human immunodeficiency virus in Kansas City. Clin Infect Dis 1994;18:395-400.
6. Selik RM, Starcher ET, Curran JW. Opportunistic diseases reported in AIDS patients: frequencies, associations, end bends. AIDS 1987;1:175-82.
7. Horsburgh CR, Selik RM. The epidemiology of disseminated non-tuberculous mycobacterial infection in the Acquired Immunodeficiency Syndrome (AIDS). Am Rev Respir Dis 1989;139:4-7.
8. Centers for disease control and prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-19.
9. Collins CH, Grange JM, Yates MD. Organization and practice in tuberculosis bacteriology. London: Butterworths, 1985.
10. Vinke G, Yegers O, Vanachter H, Jenkins PA, Butzler JP. Rapid susceptibility testing of Mycobacterium tuberculosis by a radiometric technique. J Antimicrob Chemother 1982;10:351-4.
11. Levine B, Chaisson RE. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced Human Immunodeficiency Virus (HIV) infection. Ann Intern Med 1991;114:861-8.
12. Sherer R, Sable R, Sonnenberg M, Cooper S, Spencer P, Schwimmer S, et al. Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome. Ann Intern Med 1986;105:710-12.
13. Valainis GT, Cardona LM, Greer DL. The spectrum of Mycobacterium kansasii disease associated with HIV-1 infected patients. J Acquired Immune Defic Syndr Hum Retrovirol 1991;4:516-20.
14. Valaris GT. Mycobacterium kansasii infection [letter]. Ann Intern Med 1991;115:496-7.
15. Hawkins CC, Gold JWM, Whimbey E, Kiehn TE, Brannon P, Cammarata R, et al. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986;105:184-8.
16. Chin DP, Hopewell PC, Yajko DM, Vittinghoff E, Horsburgh CR, Hadley WK, et al. Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteraemia in patients with human immunodeficiency virus infection. J Infect Dis 1994;169:289-95.
17. Mycobacterioses and the acquired immunodeficiency syndrome. Joint Position Paper of the American Thoracic Society and the Centers for Disease Control. Am Rev Respir Dis 1987;136:492-6.
18. Carpenter JL, Parks JM. Mycobacterium kansasii infections in patients positive for the human immunodeficiency virus. Rev Infect Dis 1991;13:789-96.
19. Ahn CH, Wallace RJ, Steele LC, Murphy DI. Sulphonamide containing regimens for disease caused by rifampicin resistant Mycobacterium kansasii. Am Rev Respir Dis 1987; 135:10-16.